Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Trial Shows Synthetic Antibody Slows Cognitive Decline

neurons

Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease. . . . → Read More: Trial Shows Synthetic Antibody Slows Cognitive Decline

Taking a Break

Camera and laptop

Regular posting will resume on Tuesday, 31 Aug. . . . → Read More: Taking a Break

Trial Shows Wearable Device Monitors Heart Rhythm Indicators

CardioWatch

Results from a clinical trial show a device worn on the wrist can measure two key indicators of heart health as accurately as an electrocardiogram. . . . → Read More: Trial Shows Wearable Device Monitors Heart Rhythm Indicators

Small Biz Grant to Advance Cancer Chemotherapy Patch

Cancer on clipboard

A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors. . . . → Read More: Small Biz Grant to Advance Cancer Chemotherapy Patch

Nasal Spray Shown to Stop Covid-19 Infection, Disease

Nasal spray

An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines. . . . → Read More: Nasal Spray Shown to Stop Covid-19 Infection, Disease

Infographic – Vaccination Rates in Developed World

Chart: fully vaccinated

As most the world’s countries struggle to vaccinate their citizens against Covid-19, rates of fully vaccinated people in developed countries vary widely. . . . → Read More: Infographic – Vaccination Rates in Developed World

AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

Lung cancer illustration

A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease. . . . → Read More: AI-Analyzed Liquid Biopsy IDs Early Lung Cancer

CEPI Funding Covid-19 Variant Vaccine

SARS-CoV-2 particle

A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI. . . . → Read More: CEPI Funding Covid-19 Variant Vaccine

Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Mature neuron

A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds. . . . → Read More: Biotech Start-Up Gains $90M for Neurodegenerative Diseases

Psychedelic Therapy Company Raises $80M in New Funds

Psilocybe aztecorum

A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds